November 23, 2020
CaaMTech to Talk Aeruginascin at Pharmacology 2020
Dr. Andrew Chadeayne will speak at the British Pharmacological Society’s Pharmacology 2020 conference
Updates
July 24, 2020
CaaMTech Synthesizes Two Novel Quaternary Trytpammonium Salts
DMPT iodide and DMALT iodide have been synthesized and structurally characterized by CaaMTech scientists
July 6, 2020
CaaMTech Synthesizes Novel Tryptamine Prophoria™, Amphoria™
CaaMTech scientists hope to unlock the euphoria experienced from the consumption of psilocybin mushrooms
July 3, 2020
CaaMTech Synthesizes and Analyzes the Salts of Two DMT Analogues
EPT hydrofumarate and MALT hydrofumarate have been structurally characterized by CaaMTech scientists
May 7, 2020
CaaMTech Collaborates with National Institutes of Health to Research Psychedelics
The Designer Drug Research Unit at the National Institute on Drug Abuse will conduct research on CaaMTech’s library of tryptamine-based compounds
April 23, 2020
CaaMTech Synthesizes Crystalline “Foxtrot”
CaaMTech researchers have synthesized crystalline 5-MeO-DALT freebase for the first time ever
April 7, 2020
CaaMTech Synthesizes Two New Crystalline Forms of Norpsilocin
“CaaMTech’s work represents a step forward towards resolving the ongoing scientific debate about these compounds.”
March 17, 2020
CaaMTech Researchers Synthesize New Crystalline Form of Miprocin
CaaMTech researchers have synthesized a new crystalline form of miprocin: Bis(4-hydroxy-N-isopropyl-N-methyltryptammonium) fumarate.
February 26, 2020
Former Canopy Growth Exec Jon Cooper Joins CaaMTech Board
Ebbu Founder & CEO led the company’s C$429M exit to Canopy Growth
November 12, 2019
CaaMTech structurally characterizes 4-HO-DPT
4-HO-DPT (formally 4-Hydroxy-N,N-di-n-propyltryptamine, also known as Procin) is a structural analogue of psilocin
